Evidence map›Paper›PMID 30104463›Full record

ArticleIET nanobiotechnology2018

Fungal xylanases-mediated synthesis of silver nanoparticles for catalytic and biomedical applications.

Joseph Adetunji Elegbede, Agbaje Lateef, Musibau Adewuyi Azeez, Tesleem Babatunde Asafa, Taofeek Akangbe Yekeen, Iyabo Christianah Oladipo, Elijah Adegoke Adebayo, Lorika Selomi Beukes, Evariste Bosco Gueguim-Kana

Abstract read
In one paragraph

Article in IET nanobiotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Journal of fungi (Basel, Switzerland) · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Joseph Adetunji ElegbedeDepartment of Pure and Applied Biology, Ladoke Akintola University of Technology, PMB 4000, Ogbomoso Nigeria.
Agbaje LateefNanotechnology Research Group (NANO), Ladoke Akintola University of Technology, PMB 4000, Ogbomoso Nigeria. agbaje72@yahoo.com;alateef@lautech.edu.ng.
Musibau Adewuyi AzeezNanotechnology Research Group (NANO), Ladoke Akintola University of Technology, PMB 4000, Ogbomoso Nigeria.
Tesleem Babatunde AsafaDepartment of Mechanical Engineering, Ladoke Akintola University of Technology, PMB 4000, Ogbomoso Nigeria.
Taofeek Akangbe YekeenNanotechnology Research Group (NANO), Ladoke Akintola University of Technology, PMB 4000, Ogbomoso Nigeria.
Iyabo Christianah OladipoDepartment of Science Laboratory Technology, Ladoke Akintola University of Technology, PMB 4000, Ogbomoso, Nigeria.
Elijah Adegoke AdebayoNanotechnology Research Group (NANO), Ladoke Akintola University of Technology, PMB 4000, Ogbomoso Nigeria.
Lorika Selomi BeukesMicroscopy and Microanalysis Unit, University of KwaZulu-Natal School of Life Sciences, Pietermaritzburg, South Africa.
Evariste Bosco Gueguim-KanaDepartment of Microbiology, School of Life Sciences, University of KwaZulu-Natal, Private Bag X01, Scottsville, PieterMaritzburg 3209, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Green synthesis of nanoparticles has fuelled the use of biomaterials to synthesise a variety of metallic nanoparticles. The current study investigates the use of xylanases of

Indexed as

AnticoagulantsAnti-Infective AgentsAntioxidantsAspergillusBiomedical TechnologyCatalysisFungiGreen Chemistry TechnologyHumansMetal NanoparticlesMicrobial Sensitivity TestsSilverTrichodermaXylosidasesAnticoagulantsAnti-Infective AgentsAntioxidantsSilverXylosidases

Identifiers

PMID30104463
PMCPMC8676439

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.